A Pleasanton-based biotechnology and pharmaceutical research company has agreed to pay a civil fine of more than $500,000 to the U.S. Department of Justice to resolve allegations that it received small business grants despite being ineligible.

Cyion Technologies LLC was accused of receiving two grants from the National Institutes of Health in 2017 and 2023, the DOJ said in a statement Friday.

The company agreed to pay just under $530,000 to settle a civil suit accusing it of violating the False Claims Act by accepting the small business grants while a key employee was working full-time for an outside employer. That violated the grants’ terms.

The criteria for the Small Business Technology Transfer and Small Business Innovation Research grants prohibited recipients’ principal investigators from holding other employment. A principal investigator is the person responsible for the design, implementation and oversight of a research project, according to the University of California, Berkeley.

The company drew funds from the grants from 2019 to 2024, according to the DOJ.

The case was prosecuted by attorneys with the U.S. Attorney’s Office for the Northern District of California.